ClinicalTrials.gg
RecruitingNCT07894510Updated Oct 26, 2026

Nanohydroxyapatite Versus Sodium Fluoride Varnish in Remineralizing MIH Anterior Teeth

An interventional study of Nanohydroxyapatite Varnish Application and Sodium Fluoride Varnish Application in Fluoride Varnishes, Molar Incisor Hypomineralisation and Permanent Anterior Teeth, sponsored by Tanta University. Recruiting at 1 site in Egypt. Open to participants aged 8 Years to 11 Years. Per ClinicalTrials.gov, last updated 2026-10-26.

Sponsored by Tanta University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 9 months after the study started (first participant enrolled Jan 2026, registered Oct 2026).
  • Started Jan 2026; still recruiting 9 months later.
Updated Oct 26, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
26
Allocation
Randomized
Ages
8 Years to 11 Years
Sex
All
01

Study summary

This randomized controlled clinical trial evaluates and compares the remineralization efficacy of a 8.6% nanohydroxyapatite (nano-HAp) varnish versus a standard 5% sodium fluoride (NaF) varnish in young permanent anterior teeth affected by Molar Incisor Hypomineralization (MIH).

Read the detailed description

Twenty-six children aged 8 to 11 years presenting with non-cavitated initial carious lesions (ICDAS scores 1 or 2) on MIH-affected permanent incisors are randomly allocated into two equal groups (n = 13 per group). Group I receives topical application of nano-HAp varnish (Fygg Varnish), while Group II receives 5% NaF varnish (Profluorid Varnish). Both groups follow standardized home care using non-fluoridated toothpaste. Remineralization and lesion progression are objectively evaluated at 1, 3, and 6 months post-application using International Caries Detection and Assessment System (ICDAS) scores and laser fluorescence (DIAGNOdent) quantitative readings.

02

Conditions studied

  • Fluoride Varnishes
  • Molar Incisor Hypomineralisation
  • Permanent Anterior Teeth
  • Remineralization

Keywords

  • Nanohydroxyapatite
  • Sodium Fluoride Varnishes
  • Permanent Anterior Teeth
  • Molar Incisor Hypomineralisation
03

In context

Molar Hypomineralization

128 studies on the registry are indexed under Molar Hypomineralization; 43 are open to participants now.

This study's planned enrollment of 26 is below the median of 52 across 99 interventional studies indexed under Molar Hypomineralization.

Browse Molar Hypomineralization studies →

Lead sponsor

Tanta University is the lead sponsor of 991 studies on the registry; 316 are open to participants now.

Of its 16 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
8 Years to 11 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Child had one or more MIH-affected permanent incisors exhibiting a non-cavitated initial carious lesion on the labial surface.
  • Lesions with a score of 1 or 2 according to the International Caries Detection and Assessment System (ICDAS).
  • Healthy children without any systemic disease.

Exclusion criteria

Exclusion Criteria:

  • Severely decayed, fractured, or restored MIH-affected teeth that can't be evaluated for varnish effects.
  • Presence of orthodontic appliances.
  • Developmental defects of enamel other than MIH (Amelogenesis imperfecta, dentinogenesis imperfecta, erosion, dental fluorosis).
  • Uncooperative patient and parent.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
26 participants (estimated)

Study arms

  • Experimental
    group-1: Nano-Hydroxyapatite Varnish

    Young permanent incisors with non-cavitated MIH enamel lesions (ICDAS 1 or 2) treated with 8.6% nanohydroxyapatite varnish.

    Procedure: Nanohydroxyapatite Varnish Application

  • Active comparator
    Group-2: Sodium Fluoride Varnish

    Young permanent incisors with non-cavitated MIH enamel lesions (ICDAS 1 or 2) treated with 5% sodium fluoride varnish.

    Procedure: Sodium Fluoride Varnish Application

Interventions

  • ProcedureNanohydroxyapatite Varnish Application

    Preparation: Professional prophylaxis of target labial surface with non-fluoridated pumice and rubber cup, followed by partial isolation using cheek retractors, high-volume suction, and cotton rolls. Application: A dime-sized amount of premixed 8.6% nano-HAp varnish is dispensed on a mixing pad and swept uniformly across the labial surface using a soft brush applicator over 15 to 30 seconds. Post-Care: Standard post-application instructions (no food/drink for 30 minutes; no brushing/flossing for 4 hours; no hot drinks/alcohol for 24 hours). Home care standardized using non-fluoridated toothpaste (Dabur Herbal) twice daily.

  • ProcedureSodium Fluoride Varnish Application

    Preparation: Identical professional prophylaxis with non-fluoridated pumice, rinsing, and moisture control isolation. Application: A thin layer of 5% NaF varnish is coated onto the target labial enamel surface using a brush applicator for 1 to 4 minutes and allowed to set upon contact with saliva. Post-Care: Identical post-application dietary restrictions and standardized home care with non-fluoridated toothpaste.

06

What researchers measure

Primary outcomes

  1. Quantitative Enamel Remineralization / Laser Fluorescence (DIAGNOdent Score)

    Objective quantitative measurement of organic component breakdown and bacterial fluorescence within the enamel lesion using a calibrated DIAGNOdent device (KaVo Dental). Measured in peak numerical fluorescence units (0-99). A reduction in DIAGNOdent value relative to baseline indicates remineralization and structural mineral gain.

    Time frame: Baseline (pre-application), 1 month, 3 months, and 6 months post-application.

Secondary outcomes

  1. Visual Caries Lesion Severity (ICDAS Score)

    Clinical visual assessment of non-cavitated MIH enamel lesions categorized according to the International Caries Detection and Assessment System (ICDAS) criteria following a 5-second air-drying step: Score 0: Sound tooth surface Score 1: First visual change in enamel (seen only after prolonged air drying) Score 2: Distinct visual change in enamel (visible when wet) Lower scores reflect lesion regression/remineralization; stable scores represent arrestment.

    Time frame: Baseline (pre-application), 1 month, 3 months, and 6 months post-application.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Amaechi BT, Tan AI, Noureldin AAK, Kanthaiah K, Holladay E, Obiefuna AC, Vijayaraghavan M. In vitro evaluation of the ability of nanohydroxyapatite toothpastes to enhance remineralization of enamel caries lesion. J Dent. 2025 Oct;161:106006. doi: 10.1016/j.jdent.2025.106006. Epub 2025 Jul 29. PubMed 40744295 ↗
  • Hamed S, Abd El Latief MH, El-Wassefy NA, Montasser MA. Fluoride-amorphous calcium phosphate and biomimetic nano-hydroxyapatite for enamel remineralization: An in-vitro study of surface microhardness and composition. Int Orthod. 2024 Jun;22(2):100865. doi: 10.1016/j.ortho.2024.100865. Epub 2024 Mar 7. PubMed 38457899 ↗
09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2026 (actual). Primary completion is estimated for Nov 2026, 10 months after the start.

Of 58 non-industry interventional studies with no phase under Molar Hypomineralization, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 25. This study's planned 10 months is below that.

Counting every sponsor, half of 58 studies reached it within 14 months; a quarter within 10 and three quarters within 25.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 19, 2026
First posted
Oct 26, 2026
StartActual
Jan 3, 2026
Primary completionEst.
Nov 2026
CompletionEst.
Dec 2026
Last update
Oct 26, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 26, 2026
Show all 1 update
  1. Oct 26, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07894510
Lead sponsor
Tanta University
Responsible party
Shaimaa Shaban Mohamed El-desouky (assistant professor of pediatric dentistry, Tanta University) — Principal investigator
First posted
Oct 26, 2026
Start date
Jan 3, 2026
Primary completion
Nov 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Oct 26, 2026

Study contacts

shaimaa eldesouky, assistant professor
Contact
shaimaaeldesouky@dent.tanta.edu.eg
01008994242
Nouran Mohsen Elsayed Basiouny, master
Contact
01202518662

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion